PMID: 15387395Sep 25, 2004Paper

A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population

International Journal of Psychiatry in Medicine
Dennis Ross-DegnanStephen B Soumerai

Abstract

Benzodiazepines (BZs) are safe, effective drugs for treating anxiety, sleep, bipolar, and convulsive disorders, but concern is often expressed about their overuse and potential for abuse. We evaluated the effects of physician surveillance through a Triplicate Prescription Program (TPP) on problematic and non-problematic BZ use. This study uses interrupted time series analyses of BZ use in the New York (intervention) and New Jersey (control) Medicaid programs for 12 months before and 24 months after the New York BZ TPP. The regulation required NY physicians to order BZs on triplicate prescription forms with one copy forwarded by pharmacies to a state surveillance unit. Study participants were community-dwelling persons over age 18 continuously enrolled between January 1988 and December 1990 in New York (n = 125,837) or New Jersey Medicaid (n = 139,405). During the baseline year, 20.2% of New York and 19.3% of New Jersey cohort members received at least one BZ prescription. After the TPP, there was a sudden, sustained reduction in BZ use of 54.8% (95% CI = [51.4%, 58.3%]) in New York with no changes in New Jersey. Significantly greater reductions were experienced by young women, and persons living in zip codes that were urban, pr...Continue Reading

References

Feb 1, 1976·Medical Care·C F FederspielW Schaffner
Dec 1, 1992·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·M Regenstein
Nov 6, 1991·JAMA : the Journal of the American Medical Association·M WeintraubL Guttmacher
Sep 1, 1991·Journal of Clinical Pharmacology·R I ShaderM B Balter
Feb 1, 1992·Disease-a-month : DM·J G Ouslander
Aug 1, 1991·Clinical Pharmacology and Therapeutics·M M Reidenberg
Jul 1, 1991·General Hospital Psychiatry·H I Schwartz, K Blank
Oct 10, 1991·The New England Journal of Medicine·S B SoumeraiI Choodnovskiy
Feb 28, 1991·The New England Journal of Medicine·J M Astrachan
Jun 1, 1990·Australian Veterinary Journal·T W Robb, A D Wood
Feb 9, 1990·JAMA : the Journal of the American Medical Association·S B SoumeraiJ Avorn
Dec 15, 1989·JAMA : the Journal of the American Medical Association·W A RayW Downey
Oct 25, 1986·British Medical Journal·A FoyP Mearrick
Aug 27, 1987·The New England Journal of Medicine·S B SoumeraiS Gortmaker
Mar 1, 1995·Psychopharmacology·J H Woods, G Winger
Jan 1, 1994·Journal of Psychiatric and Mental Health Nursing·J P Dorsay, C Forchuk
Sep 1, 1993·American Journal of Public Health·D D Hallfors, L Saxe
May 13, 1993·The New England Journal of Medicine·R I Shader, D J Greenblatt
Oct 27, 1993·JAMA : the Journal of the American Medical Association·D Ross-DegnanJ H Gurwitz
Oct 1, 1995·Irish Journal of Medical Science·R SmythJ O'Connor
Jul 2, 1997·JAMA : the Journal of the American Medical Association·B HemmelgarnG Pinard
Dec 1, 1998·JAMA : the Journal of the American Medical Association·J Zhang, K F Yu
Mar 8, 2000·American Journal of Public Health·D C Des Jarlais

❮ Previous
Next ❯

Citations

Apr 28, 2010·Archives of Internal Medicine·Becky A BriesacherJerry H Gurwitz
Dec 2, 2010·Journal of Public Health Policy·Leonard J Paulozzi, Daniel D Stier
Apr 2, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Hui-wen Keri YangBruce Stuart
Jul 25, 2013·Research in Social & Administrative Pharmacy : RSAP·Yu-Chieh Chen, David H Kreling
Aug 26, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Aaron M Gilson, Paul G Kreis
Nov 25, 2011·The Journal of Pain : Official Journal of the American Pain Society·Aaron M GilsonHassan Baxi
Sep 22, 2012·Pharmacoepidemiology and Drug Safety·Linda Simoni-Wastila, Jingjing Qian
Jun 26, 2012·Journal of the American Geriatrics Society·Michael K OngSusan L Ettner
Feb 22, 2011·Journal of Clinical Pharmacy and Therapeutics·J FisherI Sketris
May 15, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Bianca BlanchSallie-Anne Pearson
Aug 11, 2015·Journal of Clinical Psychopharmacology·Carl Salzman, Richard I Shader
Feb 5, 2013·The Medical Journal of Australia·Fiona L ShandLouisa Degenhardt
Nov 14, 2019·The Cochrane Database of Systematic Reviews·Fatima Suleman, Espen Movik
Dec 11, 2019·Journal of Clinical Medicine·Erin OldenhofPetra K Staiger
May 6, 2016·The Mental Health Clinician·Allison Schmitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.